Display options
Cite
Somani VK, Aggarwal S, Singh D, et al. Identification of Novel Raft Marker Protein, FlotP in Bacillus anthracis. Front Microbiol. 2016;7:169doi: 10.3389/fmicb.2016.00169.
Somani, V. K., Aggarwal, S., Singh, D., Prasad, T., & Bhatnagar, R. (2016). Identification of Novel Raft Marker Protein, FlotP in Bacillus anthracis. Frontiers in microbiology, 7169. https://doi.org/10.3389/fmicb.2016.00169
Somani, Vikas K, et al. "Identification of Novel Raft Marker Protein, FlotP in Bacillus anthracis." Frontiers in microbiology vol. 7 (2016): 169. doi: https://doi.org/10.3389/fmicb.2016.00169
Somani VK, Aggarwal S, Singh D, Prasad T, Bhatnagar R. Identification of Novel Raft Marker Protein, FlotP in Bacillus anthracis. Front Microbiol. 2016 Feb 17;7:169. doi: 10.3389/fmicb.2016.00169. eCollection 2016. PMID: 26925042; PMCID: PMC4756111.
Copy Download .nbib Format: NLM
Share it on

Front Microbiol. 2016 Feb 17;7:169. doi: 10.3389/fmicb.2016.00169. eCollection 2016.

Identification of Novel Raft Marker Protein, FlotP in Bacillus anthracis.

Frontiers in microbiology

Vikas K Somani, Somya Aggarwal, Damini Singh, Tulika Prasad, Rakesh Bhatnagar

Affiliations

  1. Laboratory of Molecular Biology and Genetic Engineering, School of Biotechnology, Jawaharlal Nehru University New Delhi, India.
  2. AIRF, Jawaharlal Nehru University New Delhi, India.

PMID: 26925042 PMCID: PMC4756111 DOI: 10.3389/fmicb.2016.00169

Abstract

Lipid rafts are dynamic, nanoscale assemblies of specific proteins and lipids, distributed heterogeneously on eukaryotic membrane. Flotillin-1, a conserved eukaryotic raft marker protein (RMP) harbor SPFH (Stomatin, Prohibitin, Flotillin, and HflK/C) and oligomerization domains to regulate various cellular processes through its interactions with other signaling or transport proteins. Rafts were thought to be absent in prokaryotes hitherto, but recent report of its presence and significance in physiology of Bacillus subtilis prompted us to investigate the same in pathogenic bacteria (PB) also. In prokaryotes, proteins of SPFH2a subfamily show highest identity to SPFH domain of Flotillin-1. Moreover, bacterial genome organization revealed that Flotillin homolog harboring SPFH2a domain exists in an operon with an upstream gene containing NFeD domain. Here, presence of RMP in PB was initially investigated in silico by analyzing the presence of SPFH2a, oligomerization domains in the concerned gene and NfeD domain in the adjacent upstream gene. After investigating 300 PB, four were found to harbor RMP. Among them, domains of Bas0525 (FlotP) of Bacillus anthracis (BA) showed highest identity with characteristic domains of RMP. Considering the global threat of BA as the bioterror agent, it was selected as a model for further in vitro characterization of rafts in PB. In silico and in vitro analysis showed significant similarity of FlotP with numerous attributes of Flotillin-1. Its punctate distribution on membrane with exclusive localization in detergent resistant membrane fraction; strongly favors presence of raft with RMP FlotP in BA. Furthermore, significant effect of Zaragozic acid (ZA), a raft associated lipid biosynthesis inhibitor, on several patho-physiological attributes of BA such as growth, morphology, membrane rigidity etc., were also observed. Specifically, a considerable decrease in membrane rigidity, strongly recommended presence of an unknown raft associated lipid molecule on membrane of BA. In addition, treatment with ZA decreased secretion of anthrax toxins and FlotP expression, suggesting potential role of raft in pathogenesis and physiology of BA. Thus, the present study not only suggest the existence and role of raft like entity in pathophysiology of BA but also its possible use for the development of novel drugs or vaccines against anthrax.

Keywords: Bacillus anthracis; DRM; FlotP; SPFH; flotillin; lipid raft; microdomain; pathogen

References

  1. Antimicrob Agents Chemother. 2006 Apr;50(4):1463-9 - PubMed
  2. Biochim Biophys Acta. 2008 Jul-Aug;1784(7-8):986-94 - PubMed
  3. J Mol Biol. 2001 Jan 19;305(3):567-80 - PubMed
  4. Protein J. 2005 Feb;24(2):125-31 - PubMed
  5. J Immunol Methods. 1998 Dec 1;221(1-2):35-41 - PubMed
  6. Microbiology. 1999 Feb;145 ( Pt 2):293-9 - PubMed
  7. Mol Immunol. 2010 Nov-Dec;48(1-3):264-71 - PubMed
  8. Diabetes. 2001 Sep;50(9):2148-56 - PubMed
  9. Nat Protoc. 2006;1(6):2876-90 - PubMed
  10. Biochem Biophys Res Commun. 2004 Jun 11;318(4):920-6 - PubMed
  11. J Bacteriol. 2012 Sep;194(17):4652-61 - PubMed
  12. Virol J. 2011 Oct 25;8:479 - PubMed
  13. Proc Natl Acad Sci U S A. 2012 Sep 4;109(36):14422-7 - PubMed
  14. Mol Pharmacol. 2004 Nov;66(5):1332-9 - PubMed
  15. Curr Protoc Immunol. 2002 Nov;Chapter 11:Unit 11.10 - PubMed
  16. Cold Spring Harb Perspect Biol. 2011 Oct 01;3(10):a004697 - PubMed
  17. Neurosci Lett. 2000 Aug 25;290(2):93-6 - PubMed
  18. Biochim Biophys Acta. 1978 Dec 15;515(4):367-94 - PubMed
  19. Annu Rev Biophys Biomol Struct. 2004;33:269-95 - PubMed
  20. Front Microbiol. 2013 Jun 14;4:152 - PubMed
  21. Nucleic Acids Res. 2009 Jan;37(Database issue):D459-63 - PubMed
  22. Mol Microbiol. 1997 Jan;23(1):1-10 - PubMed
  23. Biochim Biophys Acta. 2010 Nov;1804(11):2111-20 - PubMed
  24. Mol Biol Rep. 2011 Mar;38(3):2091-8 - PubMed
  25. Trends Cell Biol. 2007 Aug;17(8):394-402 - PubMed
  26. MBio. 2013 Nov 12;4(6):e00719-13 - PubMed
  27. J Lipid Res. 2006 Jul;47(7):1597-8 - PubMed
  28. BMC Evol Biol. 2009 Jan 12;9:10 - PubMed
  29. Microbiology. 2001 Jan;147(Pt 1):87-96 - PubMed
  30. Antimicrob Agents Chemother. 2003 Jul;47(7):2366-9 - PubMed
  31. Proteomics. 2006 Apr;6(7):2135-46 - PubMed
  32. Eur J Cell Biol. 2007 Sep;86(9):525-32 - PubMed
  33. Biochim Biophys Acta. 2007 Jul;1768(7):1681-90 - PubMed
  34. J Biol Chem. 1997 May 23;272(21):13793-802 - PubMed
  35. Microbiol Mol Biol Rev. 2015 Mar;79(1):81-100 - PubMed
  36. Trends Biochem Sci. 1999 Nov;24(11):425-7 - PubMed
  37. Genes Dev. 2010 Sep 1;24(17):1893-902 - PubMed
  38. J Biol Chem. 2001 May 25;276(21):18507-12 - PubMed
  39. Annu Rev Microbiol. 1989;43:89-120 - PubMed
  40. Methods Mol Biol. 2012;824:37-50 - PubMed
  41. Plasmid. 2003 May;49(3):269-80 - PubMed
  42. Genome Biol. 2003;4(11):234 - PubMed
  43. Microbiology. 2009 Jun;155(Pt 6):1786-99 - PubMed
  44. Interdiscip Perspect Infect Dis. 2009;2009:642502 - PubMed
  45. Int J Med Microbiol. 2015 Sep;305(6):523-31 - PubMed
  46. Science. 2010 Jan 1;327(5961):46-50 - PubMed
  47. Mol Microbiol. 2013 Jun;88(6):1205-17 - PubMed
  48. Bioinformatics. 2005 Mar 1;21(5):617-23 - PubMed
  49. Biochem Biophys Res Commun. 2011 Jul 22;411(1):88-95 - PubMed
  50. J Biol Chem. 2003 Aug 22;278(34):32091-9 - PubMed
  51. Antimicrob Agents Chemother. 2006 Nov;50(11):3597-606 - PubMed
  52. Proc Natl Acad Sci U S A. 2010 Nov 2;107(44):19002-7 - PubMed
  53. J Bacteriol. 2006 Aug;188(15):5333-44 - PubMed
  54. Annu Rev Microbiol. 1995;49:607-39 - PubMed
  55. Cancer Lett. 2010 Jan 28;287(2):123-35 - PubMed

Publication Types